SEC Form 4/A · accession 0001613377-17-000012
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Wayne S. Springate
Officer — Sr VP of Operations
Period of report
Jun 15, 2017
Accepted (ET)
Jun 29, 2017 · 12:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to buy Common StockF1 | $0.49 | Jun 15, 2017 | A | 4,264 | A | Jun 15, 2017 | Jun 15, 2027 | Common Stock | 4,264 | 4,264 | D |
Explanation of responses
- F1Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017.